IACS hosts the sixth partnership meeting of the Refbio II biomedical research network.

18 06 2018

On June 7 and 8, the Aragonese Institute of Health Sciences IACS received representatives from nine Spanish and French institutions to review  the progress of the 20 R&D&I projects led by the Refbio II trans-Pyrenean biomedical research cooperation network.

Along with the hosting IACS, the meeting gathered the Osasuna Health Cluster, Rioja Salud, the Basque Foundation for Innovation and Health Research Bioef as well as the Basque Country’s health research institutes Biodonostia and Biocruces, the Paul Sabatier University of Toulouse, the Toulouse Hospital and the network leader Navarrabiomed. Representatives of the governments of Aragon and Navarre and the joint secretariat of POCTEFA also attented the meeting.

This session was the occasion to present the overall Refbio II Project and to define future lines of researches. These range from infectious or cardiovascular diseases to oncological diseases. IACS researchers lead five of them and actively participate in five others.

Alongwhile, representatives of the patners entities were able to discover the Centro de Investigación Biomédica de Aragón CIBA, headquarters of IACS, which hosts the main scientific and technical services, including experimental surgery, and provides services to national and international research groups.

Refbio II (2016-2020)

The biomedical research network REFBIO is an initiative coordinated by the Navarrabiomed-Miguel Servet Foundation and financed by the POCTEFA (Programme Opérationnel de Coopération Transfrontalière Espagne-France-Andorre). This network brings together the main institutions in biomedical research in the Midi-Pyrénées, Aquitaine, La Rioja, Navarre, Aragon and the Basque Country. This network was developed to support collaborations between researchers from partner institutions and third parties.

The second phase of Refbio (2016-2018) is defined as the stage during which the Cross-border Biomedical Research Network “will enable the effective transfer of biomedical R&D results and their development in the Pyrenean zone”.

The project is 65% co-financed by the European Regional Development Fund (ERDF) under the Interreg V-A Spain-France-Andorra Programme (POCTEFA 2014-2020). The aim of POCTEFA is to strengthen the economic and social integration of the Spain-France-Andorra border area. Its support focuses on the development of cross-border economic, social and environmental activities through joint strategies for sustainable territorial development.